Search Results - "Zaidi, Syed Ziauddin A"

Refine Results
  1. 1
  2. 2
  3. 3

    Dual catastrophe of COVID-19: Massive pulmonary embolism and stroke in a previously healthy young patient: A case report by AlSheef, Mohammed, Zaidi, Abdul Rehman Z., Abonab, Majid, Obaid, Mona, Bawazir, Khalid, Zaidi, Syed Ziauddin A., Kullab, Ghaydaa J., Alawfi, Sultan, Enani, Mushira

    Published in Journal of infection and public health (01-05-2021)
    “…We are reporting a 45-year-old woman with COVID-19 who presented to the Emergency Department with a transient loss of consciousness and was found to have a…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Systemic Lupus Erythematosus Presenting as Hematoma of the Hand Due to Acquired Inhibitors to Factor VIII: Early and Prolonged Remission Achieved with Upfront Rituximab by Zaidi, Abdul Rehman Z, AlSheef, Mohammed, Motabi, Ibraheem H, Zaidi, Syed Ziauddin A, Tailor, Imran K

    Published in Curēus (Palo Alto, CA) (30-05-2019)
    “…Acquired hemophilia is a rare autoimmune disorder that is a result of antibodies against clotting factor VIII and it presents with excessive or prolonged…”
    Get full text
    Journal Article
  6. 6

    Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis by Bin Salman, Ahmed A, Zaidi, Abdul Rehman Zia, Altaf, Syed Yasir, AlShehry, Nawal F, Tailor, Imran K, Motabi, Ibraheem H, Zaidi, Syed Ziauddin A

    Published in The American journal of case reports (13-09-2020)
    “…BACKGROUND Chronic myeloid leukemia (CML) is usually a tri-phasic myeloproliferative neoplasm, characterized by the presence of the BCR-ABL1 fusion gene,…”
    Get full text
    Journal Article
  7. 7

    Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity? by Tailor, Imran K, Alshehry, Nawal F, Sabir, Kamran, Zaidi, Abdul Rehman Z, Marei, Mohammed, Motabi, Ibraheem, Alfayez, Mansour, Zaidi, Syed Ziauddin A, Altaf, Syed Y

    Published in Blood (05-11-2020)
    “…Introduction Outcomes of patients with hematological cancers and Corona Virus Disease-19 (COVID-19) have been dismal with high rates of hospitalization,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events by Al-Ammari, Maged, Peer Zada, Abdul Ali, Motabi, Ibraheem H., Albtoosh, Belal M., Altaf, Syed Y., Tailor, Imran K., Alnoamani, Mohammed S., Zaidi, Syed Ziauddin A, Alfayez, Mansour, Alshehry, Nawal F, Marei, Mohammed A.

    Published in Blood (23-11-2021)
    “…Background: JAK2 GGCC 46/1 haplotype can be represented by four main SNPs (rs3780367, rs10974944, rs12343867, and rs1159782) which replace one cytosine and…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Efficacy of High Dose Chemotherapy with Autologous Transplantation for Primary CNS Lymphoma Treatment by Sana, Muhammad Khawar, Abdullah, Syed Maaz, Tayyeb, Muhammad, Ammad Ud Din, Mohammad, Ehsan, Amrat, Dar, Abdul Jabbar, Khurshid, Qasim, Abdullah, Sikander, Neupane, Karun, Haider, Mobeen Zaka, Khalil, Muhammad Jahanzeb, Ehsan, Hamid, Zaidi, Syed Ziauddin A, Anwer, Faiz

    Published in Blood (05-11-2020)
    “…Primary CNS lymphoma (PCNSL) is a highly aggressive non-Hodgkin lymphoma (NHL) variant limited to the CNS with rare evidence of systemic spread. It constitutes…”
    Get full text
    Journal Article
  14. 14

    Phase 2 Study of 5 Days Azacytidine Priming Prior to Fludarabine, Cytarabine and G-CSF Combination for Patients with Relapsed or Refractory AML by Motabi, Ibraheem H., Iqbal, Shahid, Zaidi, Syed Ziauddin A., Albtoosh, Belal, Alshehry, Nawal Faiez, AlGhamdi, Mubarak S., Tailor, Imran Khan, Altaf, Syed

    Published in Blood (29-11-2018)
    “…Background: Acute Myeloid Leukemia (AML) is a group of heterogeneous clonal disorder of myeloid progenitor cells. Relapsed and refractory AML represent a…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Primary Central Nervous System Lymphoma Treatment Outcomes-a Decade's Experience from a Single Centre in Riyadh, Saudi Arabia by Tailor, Imran K, Hussain, Taimoor, Shakweer, Wafa, Motabi, Ibraheem H, Murtaza, Ghulam, Zaidi, Syed Ziauddin A., Shehry, Nawal F, AlGhamdi, Mubarak S., Bayoumi, Yasser, Mudaibigh, Samer

    Published in Blood (02-12-2016)
    “…Background: Primary central nervous system lymphoma (PCNL) is relatively uncommon type of lymphoid malignancy and there is paucity of data on the incidence and…”
    Get full text
    Journal Article
  18. 18

    Doublet Versus Triplet PET: Is END of Therapy PET Needed IF Interim PET Is Negative in Hodgkin'S or Diffuse Large B CELL Lymphoma? by Tailor, Imran K, Btoosh, Bilal, Hamdy, Shaimaa, Raja, Shanker, Alharbi, Mohammed O, Motabi, Ibraheem H, Alshehry, Nawal Faiez, Qureshi, Mohammed S, AlGhamdi, Mubarak S., Zaidi, Syed Ziauddin A.

    Published in Blood (02-12-2016)
    “…Introduction: Baseline (PETb) and end of therapy (PETe) FDG PET is standard of care in the management of hodgkin's lymphoma (HL) and diffuse large B cell…”
    Get full text
    Journal Article
  19. 19
  20. 20